Here, we were interested if MSC were alone and when in glioblastoma microenvironment express CCL5 and CCR5. Therefore, we have immunolabeled bone marrow-derived MSCs in monocultures by CCL5 and CCR5 antibodies and demonstrated high expression of both antigens in MSCs (Figure S1). The gene discussed is CCR5; the disease is glioblastoma.